Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Access Starts Pre-Licensing Program Relating To Cobalamin Technology
Cobalamin is Access’ proprietary technology based upon the use of vitamin B12 for targeted delivery of drugs to disease sites and for oral drug delivery of drugs that
Cobalamin is Access’ proprietary technology based upon the use of vitamin B12 for targeted delivery of drugs to disease sites and for oral drug delivery of drugs that
The company said that the new SensiGene Fetal RhD Genotyping test is designed to detect circulating cell-free fetal (ccff) DNA from maternal blood and examine multiple regions of
The Israeli patent extends the company’s current patent portfolio, which includes VIP patents in the US, Singapore, New Zealand, China, South Korea and the European Union. Israeli Patent
The study was conducted in approximately 100 clinical sites throughout North America and Europe. The company plans to use data from the study to support submission of a
Reportedly, in 2006, Aradigm has sold all assets related to the Intraject needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
The company claims that its drug response marker has pioneered a method of identifying cancer cell response and sensitivity to various chemotherapeutic and biologic agents at the biopsy
The company had completed the 96 week dosing for the phase IIb trials in 2008, which demonstrated that after dosing, patients with HIV levels below detectable was over
Decapeptyl LP 22.5mg is available as 1-3 months sustained release formulations and also daily formulation. Decapeptyl releases hormone (GnRH) agonist analogue over a period of time. The company
5P12-RANTES is a microbicides, developed with a purpose of preventing HIV from spreading. The clinical trial will be conducted to prove the safety of the microbicide. The company
Cetirizine Hydrochloride solution 1mg/ml is the generic equivalent of McNeil Consumer Healthcare Children’s Zyrtec Oral solution for allergy, 1mg/ml, and Children’s Zyrtec Oral solution for hives relief, 1mg/ml.